Influenza Clinical Trials in Houston, Texas

4 studies are recruiting for influenza in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

   Influenza virus is a significant pathogen in pediatric solid organ transplant (SOT) recipients. However, these individuals respond poorly to standard-dose (SD) inactivated influenza vaccine (IIV). Recent studies have investigated two strategies to overcome poor immune responses in SOT recipients: (…

   Stage

   Phase 2

   Ages

   3 to 17

   Site

   Texas Children's Hospital, Houston, Texas

   Locations

   11 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT05947071 on ClinicalTrials.gov

2. A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

   Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000 deaths per year (WHO 2025). Yearly administration of an influenza vaccine for the prevention of influenza is currently recommended. However, the real…

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Elevate Clinical Research - Houston ( Site 0589), Houston, Texas

   Locations

   185 in total

   Run by

   Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

   See if you can join NCT07159763 on ClinicalTrials.gov

3. A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

   This study consists of two parts: Part A Surveillance and Part B Transmission. The main purpose of Part A is to evaluate the prevalence of pre-dose and treatment-emergent amino acid substitutions in pediatric participants' <12 years with influenza treated with baloxavir marboxil. Part B will includ…

   Stage

   Phase 3

   Ages

   0 to 11

   Site

   Pioneer Research Solutions, Houston, Texas

   Locations

   51 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT06094010 on ClinicalTrials.gov

4. Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

   This phase II trial studies the effect of baloxavir in combination with oseltamivir in treating severe influenza infection in patients who have previously received a hematopoietic (blood) stem cell transplant or have a hematological malignancy. Baloxavir is an antiviral drug that inhibits the growt…

   Stage

   Phase 2

   Ages

   12 and older

   Site

   M D Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT04712539 on ClinicalTrials.gov